Date: 22 May 2010
Parkin Suppresses c-Jun N-terminal kinase-induced cell death via transriptional regulation in Drosophila
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Parkin is the most prevalent genetic factor in the onset of autosomal recessive juvenile parkinsonism (AR-JP), and mutations in parkin has been reported to cause motor defects, which result from dopamine deficiency caused by dopaminergic neuronal cell death. Activation of c-Jun N-terminal kinase (JNK) has also been implicated in neuronal cell death in Parkinson’s disease (PD). Moreover, Drosophila models for AR-JP, loss of function mutants of Drosophila parkin, also show dopaminergic neural degeneration associated with hyperactivation of JNK, increased apoptosis, and mitochondrial defects. However, the molecular mechanism by which Parkin protects cells from apoptosis remains unclear. In the present study, we tested whether Drosophila Parkin suppressed the JNK signaling pathway in developing tissues. Ectopically expressed parkin strongly suppressed the constitutively active form of Hemipterous (HepCA), a Drosophila JNK kinase that induces an eye degeneration phenotype and apoptosis in the eye imaginal disc. Moreover, parkin also suppressed extra vein formation induced by Basket (Bsk), a Drosophila JNK. Interestingly, the bsk mRNA level was markedly reduced by parkin over-expression, suggesting that the effect of parkin on the phenotype induced by activation of JNK signaling was achieved by transcriptional regulation. Furthermore, we found that the expression level of JNK target genes was reduced by parkin over-expression. Taken together, these results suggest that Drosophila Parkin suppresses JNK signaling by reducing bsk transcription.
The authors equally contributed to this work.
Brand, A.H., and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401–415.PubMed
Cassarino, D.S., Halvorsen, E.M., Swerdlow, R.H., Abramova, N.N., Parker, W.D., Jr., Sturgill, T.W., and Bennett, J.P., Jr. (2000). Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson’s disease. J. Neurochem. 74, 1384–1392.CrossRefPubMed
da Costa, C.A., Sunyach, C., Giaime, E., West, A., Corti, O., Brice, A., Safe, S., Abou-Sleiman, P.M., Wood, N.W., Takahashi, H., et al. (2009). Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson’s disease. Nat. Cell. Biol. 11, 1370–1375.CrossRefPubMed
Hwang, S., and Cho, K.S. (2006). Parkin inhibits Daxx-like protein-induced extra wing vein formation in Drosophila. J. Basic Sci. 31, 15–19.
Jeong, M., Cho, J., Cho, W., Shin, G., and Lee, K. (2009). The glucosamine-mediated induction of CHOP reduces the expression of inflammatory cytokines by modulating JNK and NF-κB in LPS-stimulated RAW264.7 cells. Gene & Genomics 31, 251–260.
Lang, A.E., and Lozano, A.M. (1998). Parkinson’s disease. First of two parts. N. Engl. J. Med. 339, 1044–1053.
Rinne, J.O. (1993). Nigral degeneration in Parkinson’s disease. Mov. Disord. 8, 31–35.CrossRef
Tanaka, K., Suzuki, T., and Chiba, T. (1998) The ligation systems for ubiquitin and ubiquitin-like proteins. Mol. Cells 8, 503–512.PubMed
- Parkin Suppresses c-Jun N-terminal kinase-induced cell death via transriptional regulation in Drosophila
Molecules and Cells
Volume 29, Issue 6 , pp 575-580
- Cover Date
- Print ISSN
- Online ISSN
- Korean Society for Molecular and Cellular Biology
- Additional Links
- Parkinson’s disease
- Industry Sectors